Pyridoxamine Petition Paints Better Option As Dietary Ingredient Than IND
This article was originally published in The Rose Sheet
Executive Summary
ViGuard Health says in a petition that with two IND programs for studies of pyridoxamine's potential therapeutic use formally withdrawn, FDA should rescind its 2009 decision that it did not qualify as a dietary ingredient.